Overall and event-free survival of childhood lymphoma in Greece: analysis of harmonized clinical data over a 24-year active registration period.

Leukemia & Lymphoma
Maria A KaralexiE T Petridou

Abstract

We assessed event-free (EFS) and overall (OS) survival in 676 incident cases of childhood Hodgkin (HL) and non-Hodgkin (NHL) lymphoma actively registered in Greece (1996-2019). HL-OS5-year was 96% and NHL-OS5-year 85%, whereas HL-EFS5-year was 86% and NHL-EFS5-year was 81%, notably similar to the respective OS rates (HL: 95%, NHL: 85%) in developed countries. For HL, older age at diagnosis, high maternal education and close proximity to treatment centers were linked to remarkably favorable outcomes. By contrast, stage IV patients showed worse OS and EFS. HL patients with low levels of hemoglobin were associated with worse EFS (hazard ratio: 2.81, 95% confidence intervals: 1.09-7.22). OS (76%) and EFS (73%) were poor among high-risk NHL patients and those with increased LDH (71%). The identified predictors of poor disease outcome point to the need for intensification of individualized treatments. Ongoing clinical cancer registration entailing clinical components could contribute to use of state-of-the-art treatments.

References

Sep 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Leyvraz, P Burckhardt
Apr 25, 2001·Histopathology·H K Müller-HermelinkG Ott
Feb 2, 2002·Current Oncology Reports·Sheila WeitzmanHoward J Weinstein
Oct 5, 2002·Cancer·Gemma GattaFranco Berrino
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ron S SmithSarah S Donaldson
Feb 16, 2005·Cancer·Eva Steliarova-FoucherPeter Kaatsch
Aug 12, 2005·Mayo Clinic Proceedings·Stephen M Ansell, James Armitage
Jan 2, 2008·Haematologica·Erwin H J M KemnaDorine W Swinkels
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory T ArmstrongAnn C Mertens
Jan 13, 2010·Hematology/oncology and Stem Cell Therapy·Asim BelgaumiRajeh S Sabbah
Jan 27, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Asim F Belgaumi
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine Mauz-KörholzDieter Körholz
Jun 29, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Danny R YouldenJoanne F Aitken
Apr 12, 2013·The New England Journal of Medicine·Kieron DunleavyWyndham H Wilson
May 24, 2013·Klinische Pädiatrie·A Reiter
May 6, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Angelo RosolenMitchell S Cairo
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine Mauz-KörholzDieter Körholz
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Véronique Minard-ColinCatherine Patte
Aug 16, 2016·Haematologica·Andishe AttarbaschiUNKNOWN European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Stud
Apr 6, 2017·Indian Journal of Pediatrics·Nirav ThackerBrijesh Arora
Feb 13, 2018·Clinical Medicine Insights. Oncology·Thomas J FitzGerald, Maryann Bishop-Jodoin
Apr 11, 2018·BMJ Paediatrics Open·Hugo A MartijnSaskia Mostert
Jan 25, 2019·Pediatric Blood & Cancer·Elena IsaevskaMilena Maule
Feb 8, 2019·British Journal of Haematology·Mitchell S Cairo, Auke Beishuizen
Apr 30, 2019·Journal of Pediatric Hematology/oncology·Muhammad S AshrafMohammad Y Yakoob
Sep 29, 2019·Archivos argentinos de pediatría·Asuman N KarhanMünevver Büyükpamukçu
Oct 24, 2019·Leukemia & Lymphoma·Karishma KhullarRahul R Parikh
May 5, 2020·Pediatric Hematology and Oncology·Zijun ZhenXiaofei Sun
Jun 4, 2020·The New England Journal of Medicine·Véronique Minard-ColinUNKNOWN Children’s Oncology Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.